Pfizer Inc. buy Scotiabank
Start price
14.11.25
/
50%
€21.90
Target price
14.11.26
-
Performance (%)
-0.46%
Price
13:02
€21.80
Summary
This prediction is currently active. Since the start of the prediction for Pfizer Inc. the price has only changed by -0.46%. This prediction currently runs until 14.11.26. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pfizer Inc. | -1.801% | -1.801% |
| iShares Core DAX® | -1.410% | 0.471% |
| iShares Nasdaq 100 | -0.450% | -0.305% |
| iShares Nikkei 225® | -0.224% | 5.529% |
| iShares S&P 500 | -1.095% | -0.774% |
Comments by Scotiabank for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer (NYSE:PFE) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
Ratings data for PFE provided by MarketBeat